Dr. Michelle M. Marrero, MD

Dr. Marrero practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Marrero's NPI, 1558755603, was assigned on March 26, 2015. Dr. Marrero graduated from University of Puerto Rico, Medical Sciences Campus in 2015. Dr. Marrero holds Florida license ME142924.

Dr. Marrero's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Marrero's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Marrero is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Marrero to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Marrero practices, 3 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Marrero's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Marrero is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Marrero's licenses on file in 2 states: Florida and Puerto Rico.

Dmand AI lists alzheimer's disease, cerebrovascular disease, epilepsy, essential tremor, non-alzheimer's dementia (chronic) and sleep apnea among the conditions Dr. Marrero treats.

CMS data shows 116 Medicare services from Dr. Marrero across 3 procedure codes in 2024, all of them office visits, for 76 Medicare patients. Medicare paid $14,059 for them. Every service was in an office.

CMS counts 76 Medicare patients who saw Dr. Marrero in 2024. The largest group is 75 to 84, with 34 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 1.99, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Marrero's median patient age at 70, with 70% women.

In 2024, Dr. Marrero wrote 475 Medicare Part D claims for 95 patients. 96% of them were for generic drugs. CMS names the drug for 439 of them, across 6 drugs with 11 or more claims each, at $12,603 in total drug cost. In 2023, CMS named 404 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Marrero for performance year 2024, reported as part of a group. Dr. Marrero accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Marrero as offering telehealth.

CMS Open Payments shows 2 general payments to Dr. Marrero from 2 drug and device companies from 2016 to 2017. Food and beverage make up the largest share, 100% of the total. Pfizer Inc. paid the most, $20.

Dr. Marrero graduated from University of Puerto Rico, Medical Sciences Campus in 2015.

Dr. Marrero is in network with 9 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.